A focus on strong science has helped Regeneron create an innovative, entrepreneurial, scientific environment that engages, motivates, and supports the discovery, development, and commercialization of new therapeutics.

In 1988, Leonard S. Schleifer, MD, PhD, left his research career at Cornell University to create Regeneron Pharmaceuticals, a biotechnology company based on the founding principle that a dedication to strong science would lead to important new medicines. This focus on strong science has continued over the years and will play an important role as the company embarks on commercialization.

If you possess the following attributes, we encourage you to consider a career at Regeneron: